Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 26
- CBD Market
Can Aurora right-size the ship?
Aurora moved from its stock listing from the NYSE to NASDAQ this week as part of its cost-cutting and right-sizing plans, according to a press release.
- Markets & Stocks
MGC Pharma pressing ahead with clinical trials despite Covid-19 pandemic
The company is using funding raised via the London Stock Exchange to fund the studies
- Cultivation
Kanabo acquires slice of Hellenic Dynamics ahead of London Stock Exchange listing
The two companies have signed an agreement and have pointed to ‘broader potential relationship’
- Pharmaceutical
British Biotech Firm To List on the London Stock Exchange With A Valuation of Over £50m
BIOTECH company Oxford Cannabinoid Technologies to float on the London Stock Exchange in a listing which is set to value it at £51.5m It says it will raise £16.5m from a ‘heavily oversubscribed’ initial public offering and enter the market this Friday.
- Markets & Stocks
Hellenic Dynamics to become latest cannabis firm to list on LSE
The Greek medical cannabis company will become the first of its kind to list on the capital’s prestigious market
- Pharmaceutical
London Stock Exchange Beckons For Greek Medical Cannabis Cultivator As Market Momentum Builds
GREEK medical cannabis company Hellenic Dynamics is set to list on the London Stock Exchange as investment appetite for the sector continues to accelerate.
- Markets & Stocks
The CSE is ready to Ascend
Boston-based Ascend Wellness began trading ($AAWH) on the Canadian Securities Exchange yesterday, and Forbes is calling it “the most anticipated cannabis IPO of the year” (although they also note the IPO was just announced in April).
- CBD Market
Valens takes the Green Road south
Kelowna-based The Valens Company’s US market strategy is giving us hope for Canadian cannabis after making a $40 million deal (USD) in the American CBD market.
- Pharmaceutical
Markets: Consumer Giant’s Cannabis Move, Marlboro Maker Ponders, $120m Of CBD Deals, Zoetic Brings It Home, et al…
GLOBAL consumer brand Colgate-Palmolive is reaping the benefits of last year’s purchase of Hello Products with the launch of three oral care patents featuring cannabidiol (CBD).
- Companies
MGC Pharma releases first market report after historic LSE listing
The Australia-based company has reported record sales of its pharmaceutical products
- Markets & Stocks
LSE Cannabis Debutant Company MGC Pharma Set ‘To Break Even This Year’
THE London Stock Exchange’s medical cannabis debutant MGC Pharmaceuticals has released is first quarterly update since listing showing record revenues of almost £500,000.
- Markets & Stocks
London-Listed Medical Cannabis Firm Purchases Israeli Clinical Trial Specialist
LONDON Stock Exchange-listed MGC Pharmaceuticals is to acquire Israeli clinical trial specialist MediCaNL for £3.3m (A$6m) in a share-based transaction.
